{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:57:53Z","timestamp":1791082673831,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007710","name":"University of Connecticut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ymthe.2024.10.020","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T15:59:06Z","timestamp":1731427146000},"page":"4383-4400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Efficient and selective kidney targeting by chemically modified carbohydrate conjugates"],"prefix":"10.1016","volume":"32","author":[{"given":"Vikas","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniket","family":"Wahane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Shen","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Somlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4514-8004","authenticated-orcid":false,"given":"Raman","family":"Bahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.10.020_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100416","article-title":"Antisense technology: A review","volume":"296","author":"Crooke","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.10.020_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2024.10.020_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic antisense oligonucleotides are coming of age","volume":"70","author":"Bennett","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymthe.2024.10.020_bib4","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2024.10.020_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.10.020_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature13905","article-title":"MicroRNA silencing for cancer therapy targeted to the tumour microenvironment","volume":"518","author":"Cheng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.10.020_bib7","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","article-title":"Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates","volume":"40","author":"Brown","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.10.020_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115073","article-title":"RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges","volume":"201","author":"Won Lee","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2024.10.020_bib9","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1021\/acsnano.2c12140","article-title":"Spotlight on Genetic Kidney Diseases: A Call for Drug Delivery and Nanomedicine Solutions","volume":"17","author":"Trac","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2024.10.020_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003205","article-title":"MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways","volume":"4","author":"Chau","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.10.020_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI75852","article-title":"Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways","volume":"125","author":"Gomez","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.10.020_bib12","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1038\/s41467-019-11918-y","article-title":"Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.020_bib13","doi-asserted-by":"crossref","first-page":"10765","DOI":"10.1073\/pnas.1301693110","article-title":"miR-17\u223c92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease","volume":"110","author":"Patel","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.10.020_bib14","article-title":"MicroRNA-27a Induces Mesangial Cell Injury by Targeting of PPAR\u03b3 and its In\u00a0Vivo Knockdown Prevents Progression of Diabetic Nephropathy","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.10.020_bib15","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.ymthe.2022.04.007","article-title":"Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice","volume":"30","author":"Yang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.10.020_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126124","article-title":"Antisense oligonucleotide treatment ameliorates IFN-\u03b3-induced proteinuria in APOL1-transgenic mice","volume":"4","author":"Aghajan","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2024.10.020_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1745-7254.2008.00772.x","article-title":"Effect of TGF-\u03b21 antisense oligodeoxynucleotide on renal function in chronic renal failure rats","volume":"29","author":"Hiong","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ymthe.2024.10.020_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2024.10.020_bib19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/dmd.121.000417","article-title":"Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration\u2013Approved Antisense Oligonucleotide Drugs","volume":"50","author":"Migliorati","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ymthe.2024.10.020_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.11.019","article-title":"Folate-dactolisib conjugates for targeting tubular cells in polycystic kidneys","volume":"293","author":"Shi","year":"2019","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2024.10.020_bib21","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1021\/acscentsci.0c00763","article-title":"Kidney-Targeted Cytosolic Delivery of siRNA Using a Small-Sized Mirror DNA Tetrahedron for Enhanced Potency","volume":"6","author":"Thai","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ymthe.2024.10.020_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10173","article-title":"The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticles","volume":"5","author":"Huang","year":"2020","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.10.020_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121562","article-title":"Modified chitosan for effective renal delivery of siRNA to treat acute kidney injury","volume":"285","author":"Tang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2024.10.020_bib24","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1962210","article-title":"Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide","volume":"254","author":"Nielsen","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.10.020_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jconrel.2016.01.005","article-title":"Nanotechnology for delivery of peptide nucleic acids (PNAs)","volume":"240","author":"Gupta","year":"2016","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2024.10.020_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202859","article-title":"Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In\u00a0Vivo Targeting of Hepatocytes","volume":"12","author":"Kumar","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ymthe.2024.10.020_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2020.101115","article-title":"Formulation of PLGA nanoparticles containing short cationic peptide nucleic acids","volume":"7","author":"Malik","year":"2020","journal-title":"MethodsX"},{"key":"10.1016\/j.ymthe.2024.10.020_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1096\/fj.01-0995fje","article-title":"Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells","volume":"16","author":"Shaw","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2024.10.020_bib29","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/s41598-018-20731-4","article-title":"Amnionless-mediated glycosylation is crucial for cell surface targeting of cubilin in renal and intestinal cells","volume":"8","author":"Udagawa","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.10.020_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11550","article-title":"The fast-recycling receptor Megalin defines the apical recycling pathway of epithelial cells","volume":"7","author":"Perez Bay","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.020_bib31","doi-asserted-by":"crossref","first-page":"19954","DOI":"10.1016\/S0021-9258(19)88650-7","article-title":"Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides","volume":"267","author":"Monia","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.10.020_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131102","article-title":"Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis","volume":"4","author":"Price","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2024.10.020_bib33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Choi","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.10.020_bib34","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.addr.2010.07.011","article-title":"Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells","volume":"62","author":"Dolman","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2024.10.020_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41578-018-0038-3","article-title":"Transport and interactions of nanoparticles in the kidneys","volume":"3","author":"Du","year":"2018","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ymthe.2024.10.020_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-physiol-052521-121841","article-title":"How Many Cell Types Are in the Kidney and What Do They Do?","volume":"84","author":"Balzer","year":"2022","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ymthe.2024.10.020_bib37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/mp800078a","article-title":"Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan","volume":"6","author":"Yuan","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2024.10.020_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10611860701289875","article-title":"Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier","volume":"15","author":"Yuan","year":"2007","journal-title":"J.\u00a0Drug Target."},{"key":"10.1016\/j.ymthe.2024.10.020_bib39","doi-asserted-by":"crossref","first-page":"F199","DOI":"10.1152\/ajprenal.00513.2010","article-title":"Is caveolin involved in normal proximal tubule function? Presence in model PT systems but absence in\u00a0situ","volume":"300","author":"Zhuang","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ymthe.2024.10.020_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1471-4159.2009.06304.x","article-title":"Albumin endocytosis via megalin in astrocytes is caveola- and Dab-1 dependent and is required for the synthesis of the neurotrophic factor oleic acid","volume":"111","author":"Bento-Abreu","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ymthe.2024.10.020_bib41","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1046\/j.1523-1755.2000.00314.x","article-title":"Cubilin- and megalin-mediated uptake of albumin in cultured proximal tubule cells of opossum kidney","volume":"58","author":"Zhai","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2024.10.020_bib42","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1091\/mbc.e03-06-0385","article-title":"The Adaptor Protein ARH Escorts Megalin to and through Endosomes","volume":"14","author":"Nagai","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ymthe.2024.10.020_bib43","first-page":"287","article-title":"Low-molecular-weight protein competition for binding sites on renal brush border membranes","volume":"17","author":"Dreisbach","year":"1994","journal-title":"Ren. Physiol. Biochem."},{"key":"10.1016\/j.ymthe.2024.10.020_bib44","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1023\/A:1015835325321","article-title":"Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme","volume":"8","author":"Franssen","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ymthe.2024.10.020_bib45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2017.03.024","article-title":"Megalin-targeted enhanced transfection efficiency in cultured human HK-2 renal tubular proximal cells using aminoglycoside-carboxyalkyl- polyethylenimine -containing nanoplexes","volume":"523","author":"Oroojalian","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ymthe.2024.10.020_bib46","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.7150\/thno.7866","article-title":"Megalin-mediated specific uptake of chitosan\/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing","volume":"4","author":"Gao","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2024.10.020_bib47","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nbt1018-909","article-title":"Setbacks shadow microRNA therapies in the clinic","volume":"36","author":"Jones","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.10.020_bib48","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1124\/dmd.123.001446","article-title":"Pharmacokinetics and Absorption, Distribution, Metabolism and Excretion of RGLS4326 in Mouse and Monkey, an Anti-miR-17 Oligonucleotide for the Treatment of Polycystic Kidney Disease","volume":"51","author":"Kamel","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ymthe.2024.10.020_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/00313028709077125","article-title":"Experimental folic acid nephropathy","volume":"19","author":"Fink","year":"1987","journal-title":"Pathology"},{"key":"10.1016\/j.ymthe.2024.10.020_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11550","article-title":"The fast-recycling receptor Megalin defines the apical recycling pathway of epithelial cells","volume":"7","author":"Perez Bay","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.020_bib51","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1016\/S0021-9258(18)34710-0","article-title":"Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line","volume":"257","author":"Schwartz","year":"1982","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.10.020_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ddmod.2010.08.002","article-title":"Models of chronic kidney disease","volume":"7","author":"Yang","year":"2010","journal-title":"Drug Discov. Today Dis. Models"},{"key":"10.1016\/j.ymthe.2024.10.020_bib53","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1681\/ASN.2009070721","article-title":"Mouse Models of Diabetic Nephropathy","volume":"20","author":"Brosius","year":"2009","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2024.10.020_bib54","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2159-8290.CD-17-0292","article-title":"Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade","volume":"7","author":"Gu","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2024.10.020_bib55","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41588-021-00946-4","article-title":"Renal plasticity revealed through reversal of polycystic kidney disease in mice","volume":"53","author":"Dong","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.10.020_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41467-023-44410-9","article-title":"Deletion of Aurora kinase A prevents the development of polycystic kidney disease in mice","volume":"15","author":"Tham","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.020_bib57","doi-asserted-by":"crossref","first-page":"F1141","DOI":"10.1152\/ajprenal.00344.2016","article-title":"Gremlin1 plays a key role in kidney development and renal fibrosis","volume":"312","author":"Church","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T03:18:42Z","timestamp":1764818322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624006798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1525001624006798"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.020","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient and selective kidney targeting by chemically modified carbohydrate conjugates","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}